메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

News

Archive

Enhanced Immunomodulation, Anti-Apoptosis, and Improved Tear Dynamics of (PEG)-BHD1028, a Novel Adiponectin Receptor Agonist Peptide, for Treating Dry Eye Disease

Writer : Encuragen
Date : 2023-01-02 10:33:40
Views : 633

Attachments(2)

iconpharmaceutics-15-00078.pdf   (3.35MB)

iconpharmaceutics-2013718-supplementary.pdf   (0.44MB)

논문앞장.PNG

 

 

 

*자세한 사항은 첨부파일 참고 부탁드립니다.*

 

 

Website: https://www.mdpi.com/1999-4923/15/1/78





No Subject Writer Date
3 Enhanced Immunomodulation, Anti-Apoptosis, and Improved Tear Dynamics of (PEG)-BHD1028, a Novel Adiponectin Receptor Agonist Peptide, for Treating Dry Eye Disease Encuragen 2023-01-02
2 [Eucuragen]PEG-BHD1028 Peptide Regulates Insulin Resistance and Fatty Encuragen 2021-11-29
1 [PLOS ONE] Discovery of a novel potent peptide agonist to adiponectin receptor 1 Encuragen 2021-11-29